Search for: "Novartis Pharmaceuticals Corporation" Results 141 - 160 of 219
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2010, 2:40 am by Kelly
(Afro-IP) Africa: Giving consumers power in the battle against counterfeits (Afro-IP) Australia: Review Four Corners’ ‘Body Corporate’ program on gene patenting (Patentology) India: Roche and Novartis, finally, manage to defend their patents in oppositions filed by Cipla (Spicy IP) South Africa: San people push for new legislation – demand protection for indigenous knowledge and IP including medicinal remedies derived from plants including Hoodia (Afro-IP)… [read post]
3 Sep 2010, 9:43 am by Greenberg & Bederman
Some large corporations have a tendency to behave with ignorance when it comes to the internet. [read post]
25 Aug 2010, 7:37 am by Levin & Perconti
The drug is manufactured by Finnish drugmaker Orion Corporation and is marked by Swiss-based Novartis Pharmaceuticals. [read post]
30 Jul 2010, 4:06 am by Andrew Frisch
Alpharma notes that from the beginning of their employment, Alpharma PSRs receive training and instruction from Alpharma specifically designed to ensure the Alpharma Representatives did not deviate from corporate-approved messages about the drugs. [read post]
19 Jul 2010, 7:07 pm by Piper Hoffman
The latest example is Novartis, a pharmaceutical company, which settled a gender discrimination class action for up to $175 million last week. [read post]
19 Jul 2010, 4:30 pm by piperhoffman
The latest example is Novartis, a pharmaceutical company, which settled a gender discrimination class action for up to $175 million last week. [read post]
17 Jun 2010, 6:47 am by Andrew Frisch
In its brief, the DOL argues that the district court in that case committed legal error when it concluded that the pharmaceutical sales representatives employed by Novartis Pharmaceutical Corporation (“NPC”) were exempt from the overtime requirements of the FLSA under the outsides sales and administrative exemptions. [read post]
8 Jun 2010, 1:58 pm by Matthew Kadushin
Swiss pharmaceutical firm Novartis was found guilty of New York sexual harassment and discrimination last Monday by a jury and ordered to pay out $3.3 million to a dozen women who headed up a class action suit. [read post]
3 Jun 2010, 2:54 pm by Adria B. Martinelli
Pharmaceutical giant Novartis recently defended a class action lawsuit filed by thousands of its female sales representatives alleging discriminatory treatment in pay and promotions. [read post]
2 Jun 2010, 8:50 am
Department of Energy 82 Teach for America 83 Abbott 84 AT&T 85 MGM Mirage 86 Mayo Clinic 87 Lockheed Martin Corporation 88 Merck 89 Limited Brands 90 Hyatt Hotels and Resorts 91 Colgate-Palmolive Company 92 Dell Inc. 93 Lilly 94 Novartis Pharmaceuticals Corporation 95 The Vanguard Group 96 Oracle 97 Vestas 98 Wal-Mart Stores Inc. 99 Honda Companies 100 [read post]
20 May 2010, 6:24 pm by Mark Toth
On Monday, a New York jury found Novartis Pharmaceuticals Corporation liable for discriminating against female employees and awarded more than $3.3 million in compensatory damages. [read post]
17 May 2010, 7:02 am by randal shaheen
A pop-up disclaimer for this third website -- you are “moving to an external website independently operated and not managed by the Novartis Pharmaceuticals Corporation” -- did nothing to dispel FDA’s belief that Novartis was responsible for its content. [read post]
5 May 2010, 5:14 pm by FDABlog HPM
Martin – FDA just released the Warning Letter it issued to Novartis Pharmaceuticals Corporation (“Novartis”) in April regarding two purportedly unbranded websites, www.gistalliance.com and www.cmlalliance.com (the “alliance websites”), which included disease-state information and clinical data about gastrointestinal stromal tumors (“GIST”) and chronic myeloid leukemia (“CML”). [read post]
4 May 2010, 10:29 pm by Ben Vernia
According to DOJ’s press release: Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation have agreed to pay $72.5 million to resolve civil False Claims Act allegations arising from the marketing of the cystic fibrosis drug TOBI, the Justice Department announced today. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW)   General WHO documents from counterfeit meeting now online (IP… [read post]
2 Mar 2010, 6:28 am by John J. Cord
Up until now, online social networking has been treated mostly as a plaything for some pharmaceutical manufacturers. [read post]